Ratings by RBC Capital (Brian Abrahams)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/17/2024 | Sage Therapeutics | SAGE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 4/15/2024 | Marinus Pharmaceuticals | MRNS | Downgrade | Sector Perform (Outperform) |
7.52 (1.41) |
-81.25% | Details | |
| 4/11/2024 | Regeneron Pharma | REGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/13/2024 | Neumora Therapeutics | NMRA | Maintain | Outperform (N/A) |
|
Details | ||
| 3/7/2024 | MindMed | MNMD | Maintain | Outperform (N/A) |
|
Details | ||
| 3/5/2024 | Pliant Therapeutics | PLRX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/1/2024 | Xenon Pharmaceuticals | XENE | Maintain | Outperform (N/A) |
|
Details | ||
| 3/1/2024 | PTC Therapeutics | PTCT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/1/2024 | 89bio Inc. | ETNB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/29/2024 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 2/29/2024 | MindMed | MNMD | Maintain | Outperform (N/A) |
|
Details | ||
| 2/28/2024 | Pliant Therapeutics | PLRX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/27/2024 | Regeneron Pharma | REGN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/15/2024 | Sage Therapeutics | SAGE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/14/2024 | Incyte | INCY | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/14/2024 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 2/14/2024 | Gilead Sciences | GILD | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/9/2024 | IGM Biosciences | IGMS | Upgrade | Outperform (Sector Perform) |
12.95 (7.41) |
-42.78% | Details | |
| 2/7/2024 | Gilead Sciences | GILD | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/6/2024 | Vertex | VRTX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/5/2024 | Regeneron Pharma | REGN | Maintain | Outperform (N/A) |
|
Details | ||
| 1/30/2024 | HOOKIPA Pharma Inc. | HOOK | Maintain | Outperform (N/A) |
|
Details | ||
| 1/26/2024 | PTC Therapeutics | PTCT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 1/25/2024 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 1/22/2024 | Gilead Sciences | GILD | Maintain | Sector Perform (N/A) |
|
Details | ||
| 1/22/2024 | Vertex | VRTX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 1/12/2024 | Regeneron Pharma | REGN | Upgrade | Outperform (Sector Perform) |
915.97 (893.99) |
-2.4% | Details | |
| 1/12/2024 | 89bio Inc. | ETNB | Downgrade | Sector Perform (Outperform) |
11.17 (8.88) |
-20.5% | Details | |
| 1/8/2024 | Ambrx Biopharma | AMAM | Downgrade | Sector Perform (Outperform) |
13.63 (28.00) |
105.43% | Details | |
| 12/22/2023 | Karuna Therapeutics Inc. | KRTX | Downgrade | Sector Perform (Outperform) |
215.19 (329.83) |
53.27% | Details | |
| 12/14/2023 | MindMed | MNMD | Maintain | Outperform (N/A) |
|
Details | ||
| 12/14/2023 | Vertex | VRTX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 12/6/2023 | IGM Biosciences | IGMS | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/27/2023 | Xenon Pharmaceuticals | XENE | Maintain | Outperform (N/A) |
|
Details | ||
| 11/14/2023 | IGM Biosciences | IGMS | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/14/2023 | Gilead Sciences | GILD | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/14/2023 | Ambrx Biopharma | AMAM | Maintain | Outperform (N/A) |
|
Details | ||
| 11/10/2023 | Pliant Therapeutics | PLRX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/10/2023 | Neurocrine Bio. | NBIX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/9/2023 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 11/9/2023 | 89bio Inc. | ETNB | Maintain | Outperform (N/A) |
|
Details | ||
| 11/8/2023 | Sage Therapeutics | SAGE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/7/2023 | Vertex | VRTX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/3/2023 | Regeneron Pharma | REGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/3/2023 | Karyopharm Therapeutics | KPTI | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2023 | Intra-Cellular Therapies | ITCI | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2023 | Karuna Therapeutics Inc. | KRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/1/2023 | Neurocrine Bio. | NBIX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/1/2023 | Incyte | INCY | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/31/2023 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 10/30/2023 | Intra-Cellular Therapies | ITCI | Maintain | Outperform (N/A) |
|
Details | ||
| 10/27/2023 | PTC Therapeutics | PTCT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/23/2023 | Ambrx Biopharma | AMAM | Maintain | Outperform (N/A) |
|
Details | ||
| 10/11/2023 | 89bio Inc. | ETNB | Maintain | Outperform (N/A) |
|
Details | ||
| 10/10/2023 | Neumora Therapeutics | NMRA | New Coverage | Outperform (N/A) |
12.14 (10.55) |
-13.1% | Details | |
| 10/2/2023 | Enanta Pharmaceuticals | ENTA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 9/29/2023 | Vertex | VRTX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 9/27/2023 | Intercept Pharmaceuticals | ICPT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 9/20/2023 | Marinus Pharmaceuticals | MRNS | Maintain | Outperform (N/A) |
|
Details | ||
| 9/18/2023 | PTC Therapeutics | PTCT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 9/7/2023 | Sage Therapeutics | SAGE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/29/2023 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 8/21/2023 | Regeneron Pharma | REGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/11/2023 | Marinus Pharmaceuticals | MRNS | Maintain | Outperform (N/A) |
|
Details | ||
| 8/10/2023 | Pliant Therapeutics | PLRX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/10/2023 | 89bio Inc. | ETNB | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2023 | IGM Biosciences | IGMS | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/7/2023 | Galapagos NV | GLPG | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/7/2023 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2023 | Sage Therapeutics | SAGE | Downgrade | Sector Perform (Outperform) |
36.01 (13.04) |
-63.79% | Details | |
| 8/4/2023 | Regeneron Pharma | REGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/4/2023 | MindMed | MNMD | Maintain | Outperform (N/A) |
|
Details | ||
| 8/4/2023 | Karuna Therapeutics Inc. | KRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/4/2023 | Intra-Cellular Therapies | ITCI | Maintain | Outperform (N/A) |
|
Details | ||
| 8/4/2023 | Gilead Sciences | GILD | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/3/2023 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 8/3/2023 | Karyopharm Therapeutics | KPTI | Maintain | Outperform (N/A) |
|
Details | ||
| 8/2/2023 | Vertex | VRTX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/2/2023 | Neurocrine Bio. | NBIX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/2/2023 | Incyte | INCY | Maintain | Sector Perform (N/A) |
|
Details | ||
| 7/31/2023 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 7/26/2023 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 7/11/2023 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 6/28/2023 | Regeneron Pharma | REGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 6/26/2023 | Intercept Pharmaceuticals | ICPT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 6/8/2023 | Vertex | VRTX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 6/5/2023 | Neurocrine Bio. | NBIX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/24/2023 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 5/16/2023 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 5/15/2023 | IGM Biosciences | IGMS | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/12/2023 | Marinus Pharmaceuticals | MRNS | Maintain | Outperform (N/A) |
|
Details | ||
| 5/10/2023 | Pliant Therapeutics | PLRX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/9/2023 | Enanta Pharmaceuticals | ENTA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/8/2023 | Galapagos NV | GLPG | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/5/2023 | Karyopharm Therapeutics | KPTI | Maintain | Outperform (N/A) |
|
Details | ||
| 5/5/2023 | Karuna Therapeutics Inc. | KRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/5/2023 | Intra-Cellular Therapies | ITCI | Maintain | Outperform (N/A) |
|
Details | ||
| 5/5/2023 | 89bio Inc. | ETNB | Maintain | Outperform (N/A) |
|
Details | ||
| 5/4/2023 | Neurocrine Bio. | NBIX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/3/2023 | Incyte | INCY | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/2/2023 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 5/2/2023 | Vertex | VRTX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 4/28/2023 | PTC Therapeutics | PTCT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 4/28/2023 | Gilead Sciences | GILD | Maintain | Sector Perform (N/A) |
|
Details | ||
| 4/26/2023 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 4/26/2023 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 4/24/2023 | Neurocrine Bio. | NBIX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 4/10/2023 | Incyte | INCY | Downgrade | Sector Perform (Outperform) |
75.51 (52.82) |
-30.05% | Details | |
| 3/22/2023 | 89bio Inc. | ETNB | Maintain | Outperform (N/A) |
|
Details | ||
| 3/13/2023 | Sage Therapeutics | SAGE | Upgrade | Outperform (Sector Perform) |
39.56 (13.04) |
-67.04% | Details | |
| 3/8/2023 | Marinus Pharmaceuticals | MRNS | Maintain | Outperform (N/A) |
|
Details | ||
| 2/23/2023 | Karuna Therapeutics Inc. | KRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/9/2023 | Intra-Cellular Therapies | ITCI | Maintain | Outperform (N/A) |
|
Details | ||
| 2/8/2023 | Enanta Pharmaceuticals | ENTA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/7/2023 | Neurocrine Bio. | NBIX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 1/20/2023 | Marinus Pharmaceuticals | MRNS | New Coverage | Outperform (N/A) |
5.21 (1.41) |
-72.94% | Details | |
| 1/10/2023 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 1/5/2023 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 1/3/2023 | Gilead Sciences | GILD | Downgrade | Sector Perform (Outperform) |
85.85 (66.16) |
-22.94% | Details | |
| 12/19/2022 | Karuna Therapeutics Inc. | KRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 12/13/2022 | Neurocrine Bio. | NBIX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/22/2022 | Enanta Pharmaceuticals | ENTA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/16/2022 | MindMed | MNMD | New Coverage | Outperform (N/A) |
2.86 (8.91) |
211.54% | Details | |
| 11/15/2022 | HOOKIPA Pharma Inc. | HOOK | Maintain | Outperform (N/A) |
|
Details | ||
| 11/11/2022 | 89bio Inc. | ETNB | Maintain | Outperform (N/A) |
|
Details | ||
| 11/9/2022 | Pliant Therapeutics | PLRX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/8/2022 | Sage Therapeutics | SAGE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/7/2022 | Galapagos NV | GLPG | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/4/2022 | Karuna Therapeutics Inc. | KRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/4/2022 | Intra-Cellular Therapies | ITCI | Maintain | Outperform (N/A) |
|
Details | ||
| 11/4/2022 | IGM Biosciences | IGMS | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/4/2022 | Karyopharm Therapeutics | KPTI | Upgrade | Outperform (Sector Perform) |
4.54 (1.28) |
-71.81% | Details | |
| 11/3/2022 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 11/2/2022 | Neurocrine Bio. | NBIX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/2/2022 | Incyte | INCY | Maintain | Outperform (N/A) |
|
Details | ||
| 10/28/2022 | PTC Therapeutics | PTCT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/28/2022 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 10/26/2022 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 10/18/2022 | NeuBase Therapeutics | NBSE | Downgrade | Sector Perform (Outperform) |
0.31 (0.43) |
38.71% | Details | |
| 10/17/2022 | PTC Therapeutics | PTCT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/11/2022 | Xenon Pharmaceuticals | XENE | Maintain | Outperform (N/A) |
|
Details | ||
| 9/29/2022 | Karuna Therapeutics Inc. | KRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 9/28/2022 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 9/13/2022 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 9/13/2022 | 89bio Inc. | ETNB | Maintain | Outperform (N/A) |
|
Details | ||
| 9/12/2022 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 8/15/2022 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 8/12/2022 | Karuna Therapeutics Inc. | KRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/11/2022 | Pliant Therapeutics | PLRX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/9/2022 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 8/9/2022 | Enanta Pharmaceuticals | ENTA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/8/2022 | Galapagos NV | GLPG | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/5/2022 | Vertex | VRTX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/5/2022 | PTC Therapeutics | PTCT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/5/2022 | Neurocrine Bio. | NBIX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/5/2022 | Karyopharm Therapeutics | KPTI | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/4/2022 | Intercept Pharmaceuticals | ICPT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/3/2022 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 8/3/2022 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 7/22/2022 | Incyte | INCY | Maintain | Outperform (N/A) |
|
Details | ||
| 7/20/2022 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 7/11/2022 | Pliant Therapeutics | PLRX | Maintain | Outperform (N/A) |
|
Details | ||
| 7/1/2022 | Enanta Pharmaceuticals | ENTA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 6/29/2022 | 89bio Inc. | ETNB | Maintain | Outperform (N/A) |
|
Details | ||
| 6/23/2022 | PTC Therapeutics | PTCT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 6/21/2022 | PTC Therapeutics | PTCT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 6/17/2022 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 6/13/2022 | Pliant Therapeutics | PLRX | Maintain | Outperform (N/A) |
|
Details | ||
| 6/2/2022 | Sage Therapeutics | SAGE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/12/2022 | 89bio Inc. | ETNB | Maintain | Outperform (N/A) |
|
Details | ||
| 5/11/2022 | Xenon Pharmaceuticals | XENE | Maintain | Outperform (N/A) |
|
Details | ||
| 5/10/2022 | Pliant Therapeutics | PLRX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/10/2022 | Enanta Pharmaceuticals | ENTA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/9/2022 | Intercept Pharmaceuticals | ICPT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/9/2022 | Galapagos NV | GLPG | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/6/2022 | Vertex | VRTX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/5/2022 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 5/5/2022 | Neurocrine Bio. | NBIX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/4/2022 | Sage Therapeutics | SAGE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/4/2022 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 5/3/2022 | Incyte | INCY | Maintain | Outperform (N/A) |
|
Details | ||
| 4/21/2022 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 4/12/2022 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 3/30/2022 | atai Life Sciences N.V | ATAI | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/25/2022 | HOOKIPA Pharma Inc. | HOOK | Maintain | Outperform (N/A) |
|
Details | ||
| 3/7/2022 | Karyopharm Therapeutics | KPTI | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/7/2022 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 3/3/2022 | Intercept Pharmaceuticals | ICPT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/3/2022 | Biogen | BIIB | Upgrade | Outperform (Sector Perform) |
207.79 (190.52) |
-8.31% | Details | |
| 3/2/2022 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 3/1/2022 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 3/1/2022 | Pliant Therapeutics | PLRX | New Coverage | Outperform (N/A) |
9.65 (12.19) |
26.32% | Details | |
| 2/28/2022 | Intra-Cellular Therapies | ITCI | Maintain | Outperform (N/A) |
|
Details | ||
| 2/28/2022 | Galapagos NV | GLPG | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/25/2022 | Karuna Therapeutics Inc. | KRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/23/2022 | PTC Therapeutics | PTCT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/22/2022 | Karyopharm Therapeutics | KPTI | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/17/2022 | Sage Therapeutics | SAGE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/16/2022 | Karyopharm Therapeutics | KPTI | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/14/2022 | Neurocrine Bio. | NBIX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/8/2022 | Incyte | INCY | Maintain | Outperform (N/A) |
|
Details | ||
| 2/4/2022 | Biogen | BIIB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/3/2022 | Vertex | VRTX | Downgrade | Sector Perform (Outperform) |
253.57 (393.48) |
55.18% | Details | |
| 2/2/2022 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 1/27/2022 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/21/2022 | Karuna Therapeutics Inc. | KRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/18/2022 | Neurocrine Bio. | NBIX | Downgrade | Sector Perform (Outperform) |
78.36 (132.54) |
69.14% | Details | |
| 1/18/2022 | Incyte | INCY | Upgrade | Outperform (Sector Perform) |
74.88 (52.82) |
-29.46% | Details | |
| 1/7/2022 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 12/21/2021 | Intra-Cellular Therapies | ITCI | Maintain | Outperform (N/A) |
|
Details | ||
| 12/21/2021 | Biogen | BIIB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 12/13/2021 | IGM Biosciences | IGMS | Downgrade | Sector Perform (Outperform) |
49.84 (7.41) |
-85.13% | Details | |
| 12/9/2021 | Karyopharm Therapeutics | KPTI | Maintain | Sector Perform (N/A) |
|
Details | ||
| 12/8/2021 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 12/1/2021 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/24/2021 | Pliant Therapeutics | PLRX | New Coverage | Outperform (N/A) |
14.82 (12.19) |
-17.75% | Details | |
| 11/19/2021 | Enanta Pharmaceuticals | ENTA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/19/2021 | Biogen | BIIB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/16/2021 | atai Life Sciences N.V | ATAI | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/12/2021 | 89bio Inc. | ETNB | Maintain | Outperform (N/A) |
|
Details | ||
| 11/10/2021 | Intra-Cellular Therapies | ITCI | Maintain | Outperform (N/A) |
|
Details | ||
| 11/10/2021 | HOOKIPA Pharma Inc. | HOOK | Maintain | Outperform (N/A) |
|
Details | ||
| 11/8/2021 | Galapagos NV | GLPG | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/5/2021 | IGM Biosciences | IGMS | Maintain | Outperform (N/A) |
|
Details | ||
| 11/4/2021 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2021 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2021 | Merus N.V. | MRUS | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/2/2021 | Sage Therapeutics | SAGE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/2/2021 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/29/2021 | PTC Therapeutics | PTCT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/28/2021 | Xenon Pharmaceuticals | XENE | New Coverage | Outperform (N/A) |
30.09 (40.31) |
33.96% | Details | |
| 10/22/2021 | Metacrine Inc. | MTCR | Downgrade | Sector Perform (Outperform) |
3.83 (0.49) |
-87.21% | Details | |
| 10/21/2021 | Biogen | BIIB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/20/2021 | Enanta Pharmaceuticals | ENTA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/19/2021 | Intra-Cellular Therapies | ITCI | Maintain | Outperform (N/A) |
|
Details | ||
| 9/29/2021 | Biogen | BIIB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 9/23/2021 | Incyte | INCY | Maintain | Sector Perform (N/A) |
|
Details | ||
| 9/22/2021 | Biogen | BIIB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/23/2021 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 8/16/2021 | NeuBase Therapeutics | NBSE | Maintain | Outperform (N/A) |
|
Details | ||
| 8/13/2021 | 89bio Inc. | ETNB | Maintain | Outperform (N/A) |
|
Details | ||
| 8/10/2021 | Intra-Cellular Therapies | ITCI | Maintain | Outperform (N/A) |
|
Details | ||
| 8/10/2021 | IGM Biosciences | IGMS | Maintain | Outperform (N/A) |
|
Details | ||
| 8/9/2021 | Galapagos NV | GLPG | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/9/2021 | Enanta Pharmaceuticals | ENTA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/6/2021 | Enanta Pharmaceuticals | ENTA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/6/2021 | Karyopharm Therapeutics | KPTI | Downgrade | Sector Perform (Outperform) |
7.82 (4.54) |
-41.94% | Details | |
| 8/4/2021 | Sage Therapeutics | SAGE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/4/2021 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 7/30/2021 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 7/30/2021 | Intercept Pharmaceuticals | ICPT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 7/30/2021 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 7/23/2021 | Biogen | BIIB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 7/13/2021 | atai Life Sciences N.V. | ATAI | New Coverage | Sector Perform (N/A) |
19.00 (1.91) |
-89.95% | Details | |
| 6/28/2021 | Sage Therapeutics | SAGE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 6/28/2021 | Biogen | BIIB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 6/25/2021 | Incyte | INCY | Maintain | Sector Perform (N/A) |
|
Details | ||
| 6/23/2021 | Karuna Therapeutics Inc. | KRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 6/17/2021 | Constellation Pharmaceuticals | CNST | Downgrade | Sector Perform (Outperform) |
33.69 (33.99) |
0.89% | Details | |
| 6/11/2021 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 6/8/2021 | Biogen | BIIB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/14/2021 | Metacrine Inc. | MTCR | Maintain | Outperform (N/A) |
|
Details | ||
| 5/11/2021 | Intra-Cellular Therapies | ITCI | Maintain | Outperform (N/A) |
|
Details | ||
| 5/10/2021 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 5/7/2021 | Karuna Therapeutics Inc. | KRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/7/2021 | Intercept Pharmaceuticals | ICPT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/7/2021 | IGM Biosciences | IGMS | Maintain | Outperform (N/A) |
|
Details | ||
| 5/6/2021 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/5/2021 | PTC Therapeutics | PTCT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/4/2021 | Sage Therapeutics | SAGE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/4/2021 | Incyte | INCY | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/4/2021 | Karyopharm Therapeutics | KPTI | Maintain | Outperform (N/A) |
|
Details | ||
| 4/30/2021 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 4/23/2021 | Biogen | BIIB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 4/20/2021 | Ovid Therapeutics Inc | OVID | Maintain | Sector Perform (N/A) |
|
Details | ||
| 4/16/2021 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 4/7/2021 | Constellation Pharmaceuticals | CNST | Maintain | Outperform (N/A) |
|
Details | ||
| 3/31/2021 | IGM Biosciences | IGMS | Maintain | Outperform (N/A) |
|
Details | ||
| 3/29/2021 | Karyopharm Therapeutics | KPTI | Maintain | Outperform (N/A) |
|
Details | ||
| 3/29/2021 | PTC Therapeutics | PTCT | Upgrade | Sector Perform (Underperform) |
49.21 (24.69) |
-49.83% | Details | |
| 3/19/2021 | HOOKIPA Pharma Inc. | HOOK | Maintain | Outperform (Outperform) |
|
Details | ||
| 3/17/2021 | Merus N.V. | MRUS | Maintain | Sector Perform (Sector Perform) |
|
Details | ||
| 3/12/2021 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 3/5/2021 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/3/2021 | Ovid Therapeutics Inc | OVID | Downgrade | Sector Perform (Outperform) |
2.96 (3.21) |
8.45% | Details | |
| 3/2/2021 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 3/1/2021 | Karuna Therapeutics Inc. | KRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/26/2021 | Intra-Cellular Therapies | ITCI | Maintain | Outperform (N/A) |
|
Details | ||
| 2/25/2021 | Sage Therapeutics | SAGE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/24/2021 | Intercept Pharmaceuticals | ICPT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/19/2021 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/12/2021 | Karyopharm Therapeutics | KPTI | Maintain | Outperform (N/A) |
|
Details | ||
| 2/10/2021 | Incyte | INCY | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/9/2021 | Enanta Pharmaceuticals | ENTA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/9/2021 | Karuna Therapeutics Inc. | KRTX | New Coverage | Outperform (N/A) |
125.50 (329.83) |
162.81% | Details | |
| 1/29/2021 | IGM Biosciences | IGMS | New Coverage | Outperform (N/A) |
95.34 (7.41) |
-92.23% | Details | |
| 1/21/2021 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/15/2021 | Intercept Pharmaceuticals | ICPT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 1/4/2021 | Sage Therapeutics | SAGE | Downgrade | Sector Perform (Outperform) |
86.51 (13.04) |
-84.93% | Details | |
| 12/21/2020 | Karyopharm Therapeutics | KPTI | Maintain | Outperform (N/A) |
|
Details | ||
| 12/15/2020 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 12/2/2020 | Ovid Therapeutics Inc | OVID | Maintain | Outperform (N/A) |
|
Details | ||
| 12/1/2020 | Biogen | BIIB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/30/2020 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 11/30/2020 | HOOKIPA Pharma Inc. | HOOK | Maintain | Outperform (N/A) |
|
Details | ||
| 11/30/2020 | PTC Therapeutics | PTCT | Downgrade | Underperform (Sector Perform) |
63.99 (49.21) |
-23.1% | Details | |
| 11/30/2020 | Vertex | VRTX | Upgrade | Outperform (Sector Perform) |
226.71 (393.48) |
73.56% | Details | |
| 11/24/2020 | Enanta Pharmaceuticals | ENTA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/19/2020 | Biogen | BIIB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/16/2020 | Constellation Pharmaceuticals | ET | Maintain | Outperform (N/A) |
|
Details | ||
| 11/10/2020 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/10/2020 | Intercept Pharmaceuticals | ICPT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/2/2020 | Intra-Cellular Therapies | ITCI | Maintain | Outperform (N/A) |
|
Details | ||
| 10/30/2020 | Vertex | VRTX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/19/2020 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 10/19/2020 | Biogen | BIIB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/12/2020 | Metacrine Inc. | MTCR | New Coverage | Outperform (N/A) |
9.96 (0.49) |
-95.08% | Details | |
| 9/24/2020 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 9/18/2020 | Biogen | BIIB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 9/18/2020 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 9/18/2020 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 9/15/2020 | PTC Therapeutics | PTCT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 9/15/2020 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 9/10/2020 | Intra-Cellular Therapies | ITCI | Maintain | Outperform (N/A) |
|
Details | ||
| 9/8/2020 | Corbus Pharmaceuticals | CRBP | Downgrade | Sector Perform (Outperform) |
9.25 (36.53) |
294.92% | Details | |
| 8/26/2020 | Ovid Therapeutics Inc | OVID | Maintain | Outperform (N/A) |
|
Details | ||
| 8/6/2020 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 8/6/2020 | PTC Therapeutics | PTCT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/5/2020 | Karyopharm Therapeutics | KPTI | Maintain | Outperform (N/A) |
|
Details | ||
| 8/5/2020 | Incyte | INCY | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/4/2020 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/3/2020 | Incyte | INCY | Maintain | Sector Perform (N/A) |
|
Details | ||
| 7/31/2020 | Vertex | VRTX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 7/31/2020 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 7/23/2020 | Biogen | BIIB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 7/6/2020 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 6/29/2020 | Intercept Pharmaceuticals | ICPT | Downgrade | Sector Perform (Outperform) |
77.49 (19.00) |
-75.48% | Details | |
| 6/23/2020 | Karyopharm Therapeutics | KPTI | Maintain | Outperform (N/A) |
|
Details | ||
| 6/22/2020 | Biogen | BIIB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 6/18/2020 | Biogen | BIIB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 6/18/2020 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 6/16/2020 | NeuBase Therapeutics | NBSE | New Coverage | Outperform (N/A) |
10.32 (0.31) |
-97% | Details | |
| 6/12/2020 | Constellation Pharmaceuticals | CNST | Maintain | Outperform (N/A) |
|
Details | ||
| 6/8/2020 | Karyopharm Therapeutics | KPTI | Maintain | Outperform (N/A) |
|
Details | ||
| 6/8/2020 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 6/3/2020 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 5/29/2020 | Biogen | BIIB | Maintain | Outperform (N/A) |
|
Details | ||
| 5/27/2020 | Merus N.V. | MRUS | Downgrade | Sector Perform (Outperform) |
15.36 (40.47) |
163.48% | Details | |
| 5/26/2020 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 5/11/2020 | Corbus Pharmaceuticals | CRBP | Maintain | Outperform (N/A) |
|
Details | ||
| 5/11/2020 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 5/8/2020 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 5/7/2020 | Ovid Therapeutics Inc | OVID | Maintain | Outperform (N/A) |
|
Details | ||
| 5/7/2020 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 5/7/2020 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/6/2020 | Constellation Pharmaceuticals | CNST | Maintain | Outperform (N/A) |
|
Details | ||
| 5/6/2020 | Incyte | INCY | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/5/2020 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 5/1/2020 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 4/28/2020 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 4/28/2020 | Vertex | VRTX | Downgrade | Sector Perform (Outperform) |
268.51 (393.48) |
46.54% | Details | |
| 4/27/2020 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 4/23/2020 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 4/23/2020 | Biogen | BIIB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 4/23/2020 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 4/17/2020 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 4/8/2020 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 4/8/2020 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 3/25/2020 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 3/20/2020 | HOOKIPA Pharma Inc. | HOOK | Maintain | Outperform (N/A) |
|
Details | ||
| 3/18/2020 | Galapagos NV | GLPG | Upgrade | Sector Perform (Underperform) |
157.69 (28.91) |
-81.67% | Details | |
| 3/18/2020 | Sage Therapeutics | SAGE | Upgrade | Outperform (Sector Perform) |
28.80 (86.51) |
200.38% | Details | |
| 3/11/2020 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 3/9/2020 | Gilead Sciences | GILD | Downgrade | Outperform (Top Pick) |
80.22 (66.16) |
-17.53% | Details | |
| 3/3/2020 | PTC Therapeutics | PTCT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/3/2020 | Intra-Cellular Therapies | ITCI | Maintain | Outperform (N/A) |
|
Details | ||
| 3/2/2020 | Karyopharm Therapeutics | KPTI | Maintain | Outperform (N/A) |
|
Details | ||
| 2/27/2020 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 2/26/2020 | Theratechnologies Inc. | THTX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/25/2020 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 2/20/2020 | PTC Therapeutics | PTCT | Downgrade | Sector Perform (Outperform) |
59.36 (24.69) |
-58.41% | Details | |
| 2/20/2020 | Galapagos NV | GLPG | Downgrade | Underperform (Sector Perform) |
266.68 (157.69) |
-40.87% | Details | |
| 2/14/2020 | Incyte | INCY | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/11/2020 | Intra-Cellular Therapies | ITCI | Maintain | Outperform (N/A) |
|
Details | ||
| 2/7/2020 | Enanta Pharmaceuticals | ENTA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/5/2020 | Biogen | BIIB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/5/2020 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/5/2020 | Gilead Sciences | GILD | Maintain | Top Pick (N/A) |
|
Details | ||
| 2/4/2020 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/4/2020 | Gilead Sciences | GILD | Maintain | Top Pick (N/A) |
|
Details | ||
| 1/31/2020 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/30/2020 | Biogen | BIIB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 1/28/2020 | Biogen | BIIB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 1/22/2020 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 1/14/2020 | Gilead Sciences | GILD | Maintain | Top Pick (N/A) |
|
Details | ||
| 12/23/2019 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 12/20/2019 | Theratechnologies Inc. | THTX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 12/17/2019 | Proteostasis Therapeutics | PTI | Maintain | Outperform (N/A) |
|
Details | ||
| 12/13/2019 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 12/9/2019 | 89bio Inc. | ETNB | New Coverage | Outperform (N/A) |
28.60 (8.88) |
-68.95% | Details | |
| 12/5/2019 | Sage Therapeutics | SAGE | Downgrade | Sector Perform (Outperform) |
149.21 (28.80) |
-80.7% | Details | |
| 12/5/2019 | PTC Therapeutics | PTCT | Maintain | Outperform (N/A) |
|
Details | ||
| 11/29/2019 | Ovid Therapeutics Inc | OVID | Maintain | Outperform (N/A) |
|
Details | ||
| 11/25/2019 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 11/22/2019 | Enanta Pharmaceuticals | ENTA | Maintain | (Sector Perform) |
|
Details | ||
| 11/18/2019 | Biogen | BIIB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/15/2019 | Galapagos NV | GLPG | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/8/2019 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 11/7/2019 | Gilead Sciences | GILD | Maintain | Top Pick (N/A) |
|
Details | ||
| 11/7/2019 | Constellation Pharmaceuticals | CNST | Maintain | Outperform (N/A) |
|
Details | ||
| 11/5/2019 | Intercept Pharmaceuticals | ICPT | Maintain | Outperform (N/A) |
|
Details | ||
| 11/5/2019 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/1/2019 | Celgene | CELG | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/31/2019 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/30/2019 | PTC Therapeutics | PTCT | Maintain | Outperform (N/A) |
|
Details | ||
| 10/30/2019 | Incyte | INCY | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/29/2019 | Gilead Sciences | GILD | Maintain | Top Pick (N/A) |
|
Details | ||
| 10/29/2019 | Merus N.V. | MRUS | Maintain | Outperform (N/A) |
|
Details | ||
| 10/29/2019 | Galapagos NV | GLPG | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/28/2019 | Galapagos NV | GLPG | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/28/2019 | Gilead Sciences | GILD | Maintain | Top Pick (N/A) |
|
Details | ||
| 10/25/2019 | Gilead Sciences | GILD | Maintain | Top Pick (N/A) |
|
Details | ||
| 10/17/2019 | Incyte | INCY | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/14/2019 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/10/2019 | Constellation Pharmaceuticals | CNST | Maintain | Outperform (N/A) |
|
Details | ||
| 10/10/2019 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 9/26/2019 | Enanta Pharmaceuticals | ENTA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 9/24/2019 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 9/24/2019 | PTC Therapeutics | PTCT | Maintain | Outperform (N/A) |
|
Details | ||
| 9/19/2019 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 9/16/2019 | Biogen | BIIB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 9/6/2019 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 9/6/2019 | Biogen | BIIB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 9/6/2019 | Intercept Pharmaceuticals | ICPT | Maintain | Outperform (N/A) |
|
Details | ||
| 9/4/2019 | Ovid Therapeutics Inc | OVID | New Coverage | Outperform (N/A) |
1.76 (2.96) |
68.18% | Details | |
| 9/4/2019 | Constellation Pharmaceuticals | CNST | New Coverage | Outperform (N/A) |
7.11 (33.69) |
373.84% | Details | |
| 8/26/2019 | Gilead Sciences | GILD | Maintain | Top Pick (N/A) |
|
Details | ||
| 8/20/2019 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 8/16/2019 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/8/2019 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 8/8/2019 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 8/8/2019 | Proteostasis Therapeutics | PTI | Maintain | Outperform (N/A) |
|
Details | ||
| 8/8/2019 | Dynavax Technologies | DVAX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2019 | PTC Therapeutics | PTCT | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2019 | Enanta Pharmaceuticals | ENTA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/7/2019 | Alder Biopharm | ALDR | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2019 | Neurocrine Bio. | NBIX | New Coverage | Outperform (N/A) |
94.95 (132.54) |
39.59% | Details | |
| 8/1/2019 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 7/31/2019 | Incyte | INCY | Maintain | Sector Perform (N/A) |
|
Details | ||
| 7/30/2019 | Celgene | CELG | Maintain | Sector Perform (N/A) |
|
Details | ||
| 7/30/2019 | Incyte | INCY | Maintain | Sector Perform (N/A) |
|
Details | ||
| 7/29/2019 | Galapagos NV | GLPG | Maintain | Sector Perform (N/A) |
|
Details | ||
| 7/29/2019 | Gilead Sciences | GILD | Upgrade | Top Pick (Outperform) |
66.92 (80.22) |
19.87% | Details | |
| 7/24/2019 | Biogen | BIIB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 7/18/2019 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 7/17/2019 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 7/5/2019 | Karyopharm Therapeutics | KPTI | Maintain | Outperform (Outperform) |
|
Details | ||
| 7/3/2019 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 7/1/2019 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 6/21/2019 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 6/14/2019 | Enanta Pharmaceuticals | ENTA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 6/13/2019 | Intercept Pharmaceuticals | ICPT | Maintain | Outperform (N/A) |
|
Details | ||
| 6/11/2019 | Intercept Pharmaceuticals | ICPT | Maintain | Outperform (N/A) |
|
Details | ||
| 5/31/2019 | Merus N.V. | MRUS | Maintain | Outperform (N/A) |
|
Details | ||
| 5/24/2019 | Dynavax Technologies | DVAX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/23/2019 | Intercept Pharmaceuticals | ICPT | Maintain | Outperform (N/A) |
|
Details | ||
| 5/14/2019 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 5/13/2019 | HOOKIPA Pharma Inc. | HOOK | New Coverage | Outperform (N/A) |
13.84 (0.76) |
-94.51% | Details | |
| 5/9/2019 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 5/9/2019 | Dynavax Technologies | DVAX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/8/2019 | Enanta Pharmaceuticals | ENTA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/3/2019 | PTC Therapeutics | PTCT | Maintain | Outperform (N/A) |
|
Details | ||
| 5/3/2019 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 5/2/2019 | Alder Biopharm | ALDR | Maintain | Outperform (N/A) |
|
Details | ||
| 5/1/2019 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 4/25/2019 | Biogen | BIIB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 4/11/2019 | Intercept Pharmaceuticals | ICPT | Maintain | Outperform (N/A) |
|
Details | ||
| 4/3/2019 | Merus N.V. | MRUS | Upgrade | Outperform (Sector Perform) |
13.77 (15.36) |
11.55% | Details | |
| 4/3/2019 | Incyte | INCY | Downgrade | Sector Perform (Outperform) |
85.95 (52.82) |
-38.55% | Details | |
| 3/25/2019 | Biogen | BIIB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/19/2019 | PTC Therapeutics | PTCT | Maintain | Outperform (N/A) |
|
Details | ||
| 3/15/2019 | Karyopharm Therapeutics | KPTI | Maintain | Outperform (N/A) |
|
Details | ||
| 3/13/2019 | Celgene | CELG | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/1/2019 | Karyopharm Therapeutics | KPTI | Maintain | Outperform (N/A) |
|
Details | ||
| 3/1/2019 | Intercept Pharmaceuticals | ICPT | Upgrade | Outperform (Sector Perform) |
92.76 (77.49) |
-16.46% | Details | |
| 2/28/2019 | Intercept Pharmaceuticals | ICPT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/28/2019 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 2/27/2019 | Dynavax Technologies | DVAX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/27/2019 | Karyopharm Therapeutics | KPTI | Maintain | Outperform (N/A) |
|
Details | ||
| 2/26/2019 | Alder Biopharm | ALDR | Maintain | Outperform (N/A) |
|
Details | ||
| 2/22/2019 | PTC Therapeutics | PTCT | Maintain | Outperform (N/A) |
|
Details | ||
| 2/22/2019 | Immune Design | IMDZ | Downgrade | Sector Perform (Outperform) |
5.82 (5.85) |
0.52% | Details | |
| 2/20/2019 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 2/20/2019 | Intercept Pharmaceuticals | ICPT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/15/2019 | Incyte | INCY | Maintain | Outperform (N/A) |
|
Details | ||
| 2/12/2019 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 2/12/2019 | Biogen | BIIB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/11/2019 | Celgene | CELG | Maintain | Outperform (N/A) |
|
Details | ||
| 2/7/2019 | Enanta Pharmaceuticals | ENTA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/6/2019 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/5/2019 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 2/1/2019 | Celgene | CELG | Maintain | Sector Perform (N/A) |
|
Details | ||
| 1/30/2019 | Biogen | BIIB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 1/17/2019 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 1/7/2019 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 1/3/2019 | Celgene | CELG | Downgrade | Sector Perform (Outperform) |
66.64 (108.24) |
62.42% | Details | |
| 12/12/2018 | Intra-Cellular Therapies | ITCI | Maintain | Outperform (N/A) |
|
Details | ||
| 12/7/2018 | Corbus Pharmaceuticals | CRBP | New Coverage | Outperform (N/A) |
6.67 (9.25) |
38.68% | Details | |
| 11/28/2018 | Enanta Pharmaceuticals | ENTA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/26/2018 | Biogen | BIIB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/26/2018 | Karyopharm Therapeutics | KPTI | Maintain | Outperform (N/A) |
|
Details | ||
| 11/20/2018 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 11/7/2018 | Immune Design | IMDZ | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2018 | PTC Therapeutics | PTCT | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2018 | Dynavax Technologies | DVAX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/5/2018 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 11/1/2018 | Intercept Pharmaceuticals | ICPT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/31/2018 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 10/31/2018 | Incyte | INCY | Maintain | Outperform (N/A) |
|
Details | ||
| 10/26/2018 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 10/26/2018 | Galapagos NV | GLPG | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/25/2018 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/25/2018 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 10/24/2018 | Biogen | BIIB | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/18/2018 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 10/18/2018 | Proteostasis Therapeutics | PTI | Upgrade | Outperform (Sector Perform) |
1.91 (1.11) |
-41.88% | Details | |
| 10/12/2018 | Immune Design | IMDZ | Maintain | Outperform (N/A) |
|
Details | ||
| 10/9/2018 | Celgene | CELG | Maintain | Outperform (N/A) |
|
Details | ||
| 10/8/2018 | Karyopharm Therapeutics | KPTI | Maintain | Outperform (N/A) |
|
Details | ||
| 10/4/2018 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 9/26/2018 | Sarepta Therapeutics | SRPT | Maintain | Outperform (N/A) |
|
Details | ||
| 9/4/2018 | Theratechnologies Inc. | THTX | New Coverage | Sector Perform (N/A) |
8.28 (1.31) |
-84.18% | Details | |
| 8/28/2018 | PTC Therapeutics | PTCT | Maintain | Outperform (Outperform) |
|
Details | ||
| 8/17/2018 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/15/2018 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 8/15/2018 | Incyte | INCY | Upgrade | Outperform (Sector Perform) |
64.87 (85.95) |
32.5% | Details | |
| 8/15/2018 | Intercept Pharmaceuticals | ICPT | Downgrade | Sector Perform (Outperform) |
110.67 (92.76) |
-16.18% | Details |
